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Abstract
Background: Patients with affective disorders of different ages have been found to present weight changes and
different circadian activity patterns. This study assessed the effects of age, Body Mass Index (BMI) and depression
severity on the activity-rest cycle in persons with affective disorders using a novel multifactorial 24-h analysis method.
Methods: Two hundred and thirty-six participants aged between 14 and 85 years underwent 5 to 22 days of
actigraphy monitoring (mean duration = 14 days). BMI was also recorded and symptom severity was assessed with the
Hamilton Depression Rating Scale (HDRS). Participants were divided into two groups: healthy controls (n = 68) and
participants with a lifetime diagnosis of affective disorders (n = 168). First, the multiple regression method was
employed to formulate the circadian activity pattern in term of the factors age, BMI and HDRS. For each group, the
functional linear analysis method was applied to assess the relative effects of the factors. Finally, Wald-tests were used
to assess the contribution of each factor on the circadian activity pattern.
Results: In the affective disorders group, higher BMI was associated with higher activity levels from 3 am until 5.30 am
and with lower activity levels from 10 am until 10.30 pm. Older age was associated with less activity across the day,
evening, and night - from 11 am until 5.30 am. Higher HDRS scores were associated with higher activity around
1:30 am. In healthy controls, the effects of BMI and age on activity patterns were less pronounced and affected a
narrower portion of the 24-h period.
Conclusion: These findings suggest that older age and higher BMI are linked to lower daytime activity levels.
Higher BMI and worse symptom severity were also associated with nocturnal activity patterns suggestive of sleep
disturbances. The influence of age and BMI on 24-h activity profiles appear to be especially pronounced in people
with affective disorders.
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Background
Metabolic changes, such as weight gain, hypertension or
diabetes, are highly prevalent in affective disorders. For
instance, the rate of metabolic syndrome (characterized
by increases in blood pressure, elevated blood sugar
levels, abdominal obesity and/or low HDL cholesterol
levels) is twice as high in women who experience de-
pression at one stage in their lives compared to women
without a history of depression [1], while both men and
women with the metabolic syndrome have been found
to have a twofold increase in the risk for future depres-
sion [2]. Body weight, which is closely related to seden-
tary lifestyle and sleep abnormalities, is probably one of
the most prominent and readily modifiable components
of these metabolic complications and there is increasing
evidence for related metabolic pathophysiology in obes-
ity and affective disorders [3–5].
Elevated body mass index (BMI) has been reported in
both unipolar depression and bipolar disorder [6, 7].
Longitudinal studies have highlighted bidirectional asso-
ciations between BMI in the obesity range (≥30) and
depression, and that BMI in the overweight range
(BMI 25–29.99) is predictive of future depression
among adults (aged from 20 to over 60), but not
younger adults [8]. Importantly, BMI in the over-
weight range is also predictive of slower response to
antidepressants [9, 10], suggesting that weight complica-
tions could contribute to less favorable courses of illness.
On the other hand, medications commonly used to treat
affective disorders may contribute to weight gain [11].
Various aspects of the rest–activity cycle have been as-
sociated with BMI. Shorter sleep duration and greater
sleep fragmentation have been found in those with greater
BMI [12], and stronger associations between sleep dur-
ation and BMI have been found in younger age groups
[13]. In bipolar disorder, higher BMI is associated with de-
layed sleep phase [14, 15] and worse sleep disturbances
(measured by actigraphy and self-report) [16]. Lower
levels of physical activity are also linked to higher BMI in
both young and old age groups [17–20]. However, consid-
eration of activity patterns across the entire 24-h cycle is
needed to better understand how the activity-rest cycle re-
lates to BMI in people with affective disorders.
The activity-rest parameters are also influenced by
affective disorders and associated symptoms across age
groups. For example, sleep disturbances, including sleep
fragmentation and altered sleep duration, are associated
with worse affective symptoms in both young and older
adults [21–24], as is reduced daytime physical activity
[25–27]. However, given age-related differences in BMI
and the activity-rest cycle, relationships between activity
patterns and affective disorders are likely to differ as a
function of age. Specifically, BMI is well known to in-
crease with age [28]. Furthermore, the activity-rest cycle
varies considerably across the lifespan. There is a reduc-
tion in overall activity from young to old adulthood, in-
cluding reductions in both light and moderate to
vigorous physical activity, and an increase in sedentary
behavior [29, 30]. Increasing age is also accompanied by
greater variability and reduced amplitude of the 24-h ac-
tivity rhythm, reduced sleep time and increased sleep
fragmentation [31, 32]. In addition, the timing of rest
and activity also changes with age: phase delays occur in
adolescence [33] and phase advances occur from young
to middle and older adulthood [34]. Importantly, some
of these normal age-related changes in the activity-rest
cycle have been found to be more pronounced in per-
sons with a history of affective disorders [35]. This could
notably be linked to different pathophysiological mecha-
nisms underlying affective disorders in older people as
compared to younger people [36–38].
There is a need to evaluate the relative contribution of
factors such as age, BMI and depression severity on
activity-rest rest-activity patterns in those with affective
disorders. The application of Cosinor [39] or non-
parametric models [40] on actigraphy data has enabled
the quantification of parameters defining circadian
rhythms such as the amplitude, strength, and phase of
the activity-rest cycle. New techniques are now available
to characterize the influence of variables of interest at
each time point of the 24-h period. For instance, func-
tional linear modeling (FLM) [41] is a novel method
which can define the effects of a given variable on acti-
graphy time series. FLM is a subset of the Functional
Data Analysis method (FDA), an approach gaining in-
creasing attention due to its various applications in bio-
medical and behavioural research [42]. In the field of
FDA, statistical methods are employed to analyze data in
non-numeric forms such as images, graphs (e.g., trees),
or functions to obtain information from the natural form
(e.g., functions, graphs) of the data. The relation between
these functions and other variables of interest are for-
mulated via a multiple regression model. Consequently,
when this method is applied to actigraphy, the regres-
sion coefficients of the model represent associations be-
tween these variables of interest and activity across the
24-h period. In addition, this method yields valuable in-
formation about the time intervals in which the variables
of interest have the greatest influence on activity pat-
terns. This method has previously been used to compare
activity data across indices of apnea and BMI in 395 par-
ticipants presenting to a sleep clinic with suspected sleep
apnea, insomnia or restless legs syndrome [43]. Findings
showed that individuals with higher BMI had higher ac-
tivity during the night and lower activity during the day.
The current study aimed to examine 24-h activity pat-
terns in persons with a lifetime history of affective disor-
ders in relation to BMI, age and depression symptom
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severity using FLM. A novel analysis tool was devel-




Participants were recruited from specialized assess-
ment and early intervention services (Youth Mental
Clinic [44, 45] and the Healthy Brain Aging Clinic at
the Brain & Mind Research Institute, Camperdown
and headspace, Campbelltown, Sydney, Australia).
One hundred and sixty-eight patients with a lifetime
history of affective disorders (primary diagnoses: anx-
iety, n = 15; bipolar, n = 35; or major depressive dis-
order, n = 118) were included in the current analysis.
Their ages ranged from 14 to 83 years and their BMI
varied from 15.5 to 49.9. Sixty-eight healthy control
participants were included for comparative purposes. Their
ages ranged from 18 to 85 years and their BMI ranged from
16 to 34.6. Table 1 reports demographic information.
Lifetime diagnosis of affective disorders was deter-
mined by a psychiatrist or trained research psychologist
using DSM-IV-TR criteria [46] and current medication
information was collected. Medication information was
missing for 12 patients (7 %). Of the remaining 156 pa-
tients, 63 % were taking at least one medication. The
most common medications were SSRIs (21 %), SNRIs
(18 %), antipsychotics (18 %), and mood stabilizers/
antiepileptics (15 %). None of the control group partici-
pants reported any mental disorder. Exclusion criteria for
all participants were a history of stroke; neurological
disorder; head injury with loss of consciousness greater
than 30 min; medical condition known to affect cognition
(e.g., cancer, dementia) and other psychiatric illness.
Procedures
Wrist actigraphy was recorded using actiwatch devices
built with equivalent accelerometers and known to gen-
erate comparable data (Actiwatch-64/L/2/Spectrum,
Philips Respironics, USA [47]). Data monitoring was
conducted over five to 22 days (mean = 14 days) with 30
or 60 s epochs depending on the actiwatch model. The
Hamilton Depression Rating Scale (HDRS [48]) was ad-
ministered to all patients by a psychiatrist or trained re-
search psychologist to measure depression symptom
severity. Measures of height and weight were taken via
direct measurement (n = 142) or self-report (n = 94) for
BMI calculation. Both HDRS and BMI information were
collected within three months of actigraphy monitoring.
Functional Data Analysis (FDA)
To analyze the relationship between activity levels, age,
BMI, and HDRS, we employed the FLM. Actigraphy,
BMI, age and HDRS data were imported into the R stat-
istical software for analysis. FLM methods were applied
based on a new package adapted from the Actigraphy
package [43]. We developed additional functions and
commands within this package to integrate all parame-
ters of the model. The FDA package in R was also
employed for further analysis. FLM considers the func-
tional form of the data which can be obtained through
functional smoothing based on the curve fitting method.
Functional smoothing
Herein, the first process of FDA used functional smooth-
ing to convert discrete activity values measured at each
time unit (e.g., 30–60 s epochs) into a function. This
function represents the expected activity value at each
time point measured. The curve fitting method that we
applied on the data for smoothing purpose is the Fourier
expansion model. This model was used because of its
flexibility in representing the data as a function and its
relevance for cyclical/periodic datasets. Let ykj be the
discrete activity count for patient k at time point tkj, then
activity was described as the following equation:
ykj ¼ Activityk tkj
  þ εk tkj
 
;
where k = 1,2,…,M, and M is the total number of pa-
tients and j = 1, 2,…,Tk, where Tk is the total number of
time points for patient k. Furthermore, εk(tkj) is the error
term at each time point. The activity for all participants
was averaged for each minute across 24-h. Then the
averaged actigraphy data were converted into a func-
tional form by employing a set of basis functions
φi(t), i = 1,…,n in which their linear combinations esti-
mate Activityk(tj) as follows:
Activityk tj
  ¼ a1kφ1 tj
 þ a2kφ2 tj
 þ…þ ankφn tj
 
ð1Þ
where aik for, i = 1,…,n, are scalar coefficients for
patient k. The basis functions can be considered as
polynomials (φi (t) = a1 + a2t
2 +… + ant
n), Fourier
basis, (φi (t) = a1 + a2sin(t) + a3cos(ωt) + a4sin(2ωt) +
a5cos(2ωt) +… + a6cos(nωt)), splines and wavelets.
Note that in Eq. (1), n is the maximum number of




Age (mean(SD)) 38.8 (21.4) 35.7 (20.8)
Gender (% female) 59.7 64.7
HDRS (mean(SD)) - 11.5 (7.6)
BMI (mean(SD)) 24.8 (4.47) 25.4 (6.0)
SD standard deviation; HDRS Hamilton Depression Rating Scale; BMI Body
Mass Index
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basis functions. We have applied different basis func-
tions which give the same results. We used n = 21
Fourier basis functions to estimate the patient's ac-
tivity level in Eq. 1 which captures the major trend
with reduced noise. The Fourier basis functions are
as follows:
φ1 tð Þ ¼ 1; φ2 tð Þ ¼ cos tð Þ; φ3 tð Þ
¼ sin tð Þ ;…; φ20 tð Þ ¼ cos 21ωtð Þ; φ21 tð Þ
¼ sin 21ωtð Þ;
where T is the period, in our case T = 1440 (number of
minutes in 24 h) and ω = 2π/T. The coefficients aik,
k = 1,…,n of Eq. 1 are estimated by the least squares tech-
nique [49]. Finally, a single 24-h functional circadian
activity pattern for each participant is obtained by applying
the Fourier basis functions that can be used to estimate
patient's activity level at any time point throughout the day.
Functional linear models and multiple regressions
FLM can provide valuable insights about differences be-
tween activity patterns across different subgroups. The
relation between the circadian activity pattern, age, BMI,
and HDRS was formulated as a functional multiple re-
gression model as follows:
Activity tð Þ ¼ β0 tð Þ þ β1 tð Þ BMIþ β2 tð Þ Age
þ β3 tð Þ HDRSþ ε tð Þ;
ð2Þ
where the (t) notation indicates functions over the circa-
dian period for activity (fitted by the Fourier expansion
to the actigraphy data for each subject), Activity(t), the
circadian activity pattern, β1(t), β2(t) and β3(t) are the
functional regression coefficients indicating how the cir-
cadian activity patterns changes for different affective
disorder subjects with different BMI, age and HDRS, ε(t)
is the functional error term. Also, β0(t) is a constant
term at time t. Note that BMI, age and HDRS are used
as continuous variables (predictors) here which is con-
sidered as one of the advantages of FLM. As in the mul-
tiple regression models, we are interested in estimating
regression coefficients in Eq. (2) that produce the group-
specific mean circadian activity patterns, and test the
relative contribution of these coefficients for circadian
activity patterns in each group. Equation (2) is similarly
employed for formulating the effect of BMI and age on
the activity patterns of healthy control subjects in which
the HDRS factor is assumed to be zero. In order to ob-
tain the differences between these activity patterns in
term of all covariates, we applied F-tests. As a result, we
estimated the time intervals in which the differences are
significant. We set a global and point-wise test of signifi-
cance at a level of 0.05.
Wald-tests of regression coefficients
In order to evaluate the significance of each variable
(BMI, age, and HDRS) in the regression, Wald-tests
were employed. This test examines the probability of
obtaining zero value for each regression coefficient
β1 (t), β2 (t), and β3(t). This test for β1 (t) results in
checking the following null hypothesis:
H0: β1 tð Þ ¼ 0;
against the alternative:
Ha: β1 tð Þ≠0:
For β1(t), the t-value is defined as follows:
t ¼ β1 tð Þ=Standard−error−of− β1 tð Þ
In order to reject the null hypothesis, 2.5 and 97.5 %
percentile of t distribution (df = 167 for affective and 67
for controls) are used as critical values. If the null hy-
pothesis is rejected the regression coefficient at that time
does have an effect on the activity value. Note that the
t-value of the regression coefficient represents the con-
tribution of its covariates (BMI, Age or Depression se-
verity) to the activity value independently of the others.
Results
For presentation purposes, best-fit curves for activity
patterns over the 24-h period in relation to BMI and age
are shown in Fig. 1. From this Figure, it can be observed
that participants from the affective disorders group be-
tween 12 and 35 years of age have similar activity pat-
terns across the 24-h period, and that the overall activity
levels appear to decrease with advancing age. Further-
more, participants from the affective disorders group
with higher BMI are somewhat less active during the
daytime and more active during the nighttime.
Figure 2 shows the F-test results indicating whether
the global model integrating BMI, age and HDRS was
significantly predictive of activity levels. For the control
group, the model reached statistical significance from
about 5.30 pm until half-past midnight and again from
about 5 am to 5.30 am. For the affective disorders group,
the model reached statistical significance between ap-
proximately 10 am and 5.30 am.
After completing functional smoothing using the 21
Fourier basis functions, the regression coefficients β1(t),
β2(t) and β3(t) were obtained to reflect the effects on ac-
tivity patterns of BMI, age, and HDRS respectively.
Wald-test t values for the BMI, age and HDRS regres-
sion coefficients (determining whether each covariate
brought a significant contribution to the multiple regres-
sion model) are represented in Fig. 3. Figure 4, presents
the β1(t), β2(t) and β3(t) coefficients which reflect the
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Fig. 1 (See legend on next page.)
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magnitude and direction of the relative contribution of
each BMI, age and HDRS.
In the control group, between 5.30 pm until half-past
midnight (when F-test results were significant), lower ac-
tivity levels were significantly associated with older age
and tended to be associated with higher BMI. The influ-
ence of BMI reached statistical significance from about
7 pm to 8.30 pm. Furthermore, between 5 am to
5.30 am (i.e. another period where the global model’s
F-tests were significant), higher activity was associated
with older age and lower BMI.
In the affective disorders group, the regression coeffi-
cients reached significance on several occasions within
the time period where the model was found to be signifi-
cant (i.e. between 10 am and 5.30 am). Higher BMI was
significantly associated with higher activity levels be-
tween 3 am and 5.30 am and with lower activity levels
between approximately 10 am and 10.30 pm. Older age
was associated with lower activity levels from 11 am
until 5.30 am. Higher depression severity as measured
by the HDRS was associated with higher activity levels
around 1.30 am.
Discussion
In this study, the impact of BMI, age, and depression
symptom severity on the activity patterns of 168 persons
with a lifetime history of affective disorders and 68
healthy control participants was analyzed using an
adapted FLM technique allowing the examination of
multiple factors across all the 24-h cycle. The results
suggest that BMI and age influenced activity patterns
more broadly across the 24-h period in the affective dis-
orders group than in the control group. In the control
group, older age was associated with lower activity levels
during the evening and higher activity levels for a brief
period in the morning. Conversely, in people with
(See figure on previous page.)
Fig. 1 Circadian activity patterns over 24-h according to body mass index (BMI) and age. Different colors represent different age groups in order
to illustrate the differences in activity patterns, but this categorization was not applied in the analysis (i.e. all parameters are considered as continuous
variables). Top panel: healthy controls, Lower panel: participants with a history of affective disorders. The black arrows on top of the curves show the
reduction or increase of the activity values by growth of BMI values
Fig. 2 Results from the permutation F-test to obtain the time intervals at which the regression model significantly predicts activity levels. Top
panel: healthy controls, Lower panel: participants with a history of affective disorders
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affective disorders, age had a more widespread impact
on daytime and nighttime activity patterns, with higher
activity in those with younger ages at all times except in
the morning. This is in line with the previously reported
shift to earlier sleep-wake schedule and the overall re-
duction in activity with increasing age [29, 30, 32], but
suggests that depression may further extend age-related
decreases in activity levels. Accordingly, previous find-
ings have demonstrated altered activity patterns in
people with a history of affective disorders from different
age groups, with younger individuals showing delayed
sleep and activity schedules in comparison to older
people [35]. Furthermore, our findings are in line with
the results of Boudebesse et al. [16] which found that
higher BMI correlated with worse sleep disturbances in
people with bipolar disorder.
Within our sample of persons with a lifetime history
affective disorders, depression severity was associated
with higher activity levels in the first portion of the
night. This could notably be related to delayed sleep on-
set in a subset of these participants with more severe
depression.
BMI also had a significant influence on activity pat-
terns, especially in those with a lifetime history of
affective disorders. Higher BMI was associated with
lower activity levels across the day and higher activity
levels in the later portion of the night. Similarly, previ-
ous research highlighted that higher BMI is linked to
lower activity levels during the day time in healthy non-
depressed individuals [17–20], and to a combination of
higher nocturnal activity and lower daytime activity in
adults with suspected sleep disorders [43]. This profile is
Fig. 3 Values of the Wald-test on the regression coefficients for BMI (body mass index), age and HDRS (Hamilton Depression Rating Scale) in the
multiple regression model. Red lines represent critical t-values (two-tailed: 0.10). Top panel: healthy controls, Lower panel: participants with a history of
affective disorders
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suggestive of sedentary lifestyle and sleep disturbances,
two factors known to relate to weight gain.
Although the current findings do not yield information
about causality, one could hypothesize that the sedentary
lifestyle and poor sleep often resulting from affective dis-
orders could contribute to weight gain and higher BMI.
Elevated BMI is also commonly associated with sleep
disordered breathing [50], a condition classically leading
to multiple brief arousals during the night. In some indi-
viduals with affective disorders, it is therefore possible
that weight gain may be accompanied by more frequent
occurrences of abnormal respiratory events resulting
in more pronounced sleep fragmentation. Interest-
ingly, we observed increased nocturnal activity mostly
during the later portion of the night, a period rich in
REM sleep during which respiratory deficiencies are
more likely to occur. Since sleep disordered breathing
is also a risk factor for depression [51], it could po-
tentially preclude and/or enhance mood disturbances
in some individuals.
Although the observed modulation of activity by BMI
and age was largely independent of current depressive
symptoms within individuals with affective disorders, the
presence or absence of an affective disorder seemed to
have a considerable impact. This could suggest that
some factors specific to the presence of an affective dis-
order may potentiate the interactions between BMI and
the 24-h patterns of activity. For instance, previous find-
ings suggest that some subtypes of affective disorders
are associated with slower metabolic rate [52] and that
recovery from major depression is accompanied by an
increase in resting metabolic rate [53]. Furthermore,
antidepressant medications have been shown to slow
down resting metabolic rate in a small sample of individ-
uals with depression [54]. Importantly, in the context of
low physical activity levels, global metabolism relies
more heavily on resting metabolic rate. Consequently,
the impact of sedentary lifestyle on weight gain may be
more pronounced in depressed individuals, especially
those who take antidepressants. Since higher BMI is in
Fig. 4 Coefficients of BMI (body mass index; β1(t)), age (β2(t)) and HDRS (Hamilton Depression Rating Scale; β3(t)) in the multiple regression
models for controls (top graph) and participants with a history of affective disorders (bottom graph). Top panel: healthy controls, Lower panel:
participants with a history of affective disorders
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turn linked to higher risk of depression and slower treat-
ment response, it may be relevant to investigate whether
the effects of activity patterns on BMI relate to the
course of affective disorders, notably in terms of chron-
icity and relapse.
The present study is limited by its cross-sectional design
which does not allow conclusions to be drawn regarding
causality. In addition, while our sample of participants
ranged between 14 and 85 years of age, it contained few
middle age individuals in comparison to older and youn-
ger participants. The mean age of the control group was
higher than that of affective disorders group. In this re-
gard, a recent meta-analysis suggested that the degree of
age-matching across patient and control groups influences
group differences in sleep duration [55]. However, the
present study did not aim to directly compare participants
with and without affective disorders, but rather to investi-
gate how age, BMI and depression severity (as continuous
variables) predict changes in 24-h activity patterns within
each one of these two clinical groups separately. Also,
since our models were designed to report the relative con-
tribution of age and other variables of interests, the effects
reported for these other variables are deemed to be inde-
pendent from the effects of age. Most participants were
taking psychotropic medications, many of which are
known to influence weight and sleep, although this is
broadly representative of the clinical population. Further-
more, some of the BMI values were generated from self-
reported height and weight rather than objective measure-
ment. Also, the range of BMI was somewhat smaller in
the control group than in the affective disorders group.
Conclusion
Based on the analysis of multiple days of actigraphy
using a novel multifactorial technique, the present study
indicates that BMI and age have a considerable impact
on 24-h activity patterns. This appeared to be more
marked and widespread across the 24-h period in people
with a lifetime history of affective disorders than in
healthy controls. These findings suggest that, in the con-
text of affective disorders, older individuals and those
with higher BMI appear to be prone to more sedentary
lifestyle, while those with higher BMI and worse symp-
tom severity also present an activity profile suggestive of
restless or delayed sleep. This underscores the import-
ance of dietary, exercise, sleep and metabolic factors in
the treatment of psychiatric disorders.
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